Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 586

1.

Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.

Laws HJ, Calaminus G, Göbel U.

Cancer. 2005 Apr 15;103(8):1759; author reply 1760. No abstract available.

2.

Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.

Fioredda F, Giacchino M, Castagnola E.

Cancer. 2005 Apr 15;103(8):1758-9; author reply 1760. No abstract available.

3.

Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.

Zignol M, Peracchi M, Tridello G, Pillon M, Fregonese F, D'Elia R, Zanesco L, Cesaro S.

Cancer. 2004 Aug 1;101(3):635-41.

4.

Persistence of antibodies in 4-8 year old Austrian children after vaccination with hexavalent DTaP-HBV-IPV/Hib and MMR vaccines.

Paulke-Korinek M, Fischmeister G, Grac A, Rendi-Wagner P, Kundi M, Mohsenzadeh-Rabbani A, Moritz K, Fenninger B, Jarisch R, Jasinska J, Holzmann H, Wiedermann U, Kollaritsch H.

Vaccine. 2011 Jul 18;29(32):5130-6. doi: 10.1016/j.vaccine.2011.05.046. Epub 2011 May 30.

PMID:
21624412
5.

Current chemotherapy protocols for childhood acute lymphoblastic leukemia induce loss of humoral immunity to viral vaccination antigens.

Nilsson A, De Milito A, Engström P, Nordin M, Narita M, Grillner L, Chiodi F, Björk O.

Pediatrics. 2002 Jun;109(6):e91.

PMID:
12042585
6.

The control of diphtheria, tetanus, poliomyelitis, measles, rubella and mumps.

Dudgeon JA.

Practitioner. 1975 Sep;215(1287):299-309. Review. No abstract available.

PMID:
1101251
7.

Immunity to hepatitis B, poliomyelitis and measles in fully vaccinated aboriginal and Torres Strait Island children.

Hanna JN, Sexton WL, Faoagali JL, Buda PJ, Kennett ML, Brussen KA.

J Paediatr Child Health. 1995 Aug;31(4):345-9.

PMID:
7576896
8.

Long-term immunity to measles, mumps and rubella after MMR vaccination among children with bone marrow transplants.

Spoulou V, Giannaki M, Vounatsou M, Bakoula C, Grafakos S.

Bone Marrow Transplant. 2004 Jun;33(12):1187-90.

PMID:
15077129
9.
10.

Assessment of the potency and potential immunomodulatory effects of the measles mumps rubella and varicella vaccine in infants.

Yerkovich ST, Rowe J, Richmond P, Suriyaarachchi D, Heaton T, Hollams E, Ladyman C, Serralha M, Sadowska A, Loh R, Wesselingh SL, Sly PD, Holt PG.

Vaccine. 2007 Feb 26;25(10):1764-70. Epub 2006 Nov 27.

PMID:
17224218
11.

[Measles, mumps, rubella: important health risks].

[No authors listed]

Rev Infirm. 2000 Oct;(64):13-5. French. No abstract available.

PMID:
11288443
12.

[Indications and implementation of preventive vaccination in the inland].

Ehrengut W, Friedland R.

Internist (Berl). 1979 Jun;20(6):273-82. German. No abstract available.

PMID:
378890
13.

Immunity from diphtheria, tetanus, poliomyelitis, measles, mumps and rubella among adults in Lithuania.

Rix BA, Zhobakas A, Wachmann CH, Bakasenas V, Rønne T.

Scand J Infect Dis. 1994;26(4):459-67.

PMID:
7984979
14.

Open randomized trial comparing the immunogenicity and safety of a new measles-mumps-rubella vaccine and a licensed vaccine in 12- to 24-month-old children.

Feiterna-Sperling C, Brönnimann R, Tischer A, Stettler P, Durrer P, Gaedicke G.

Pediatr Infect Dis J. 2005 Dec;24(12):1083-8.

PMID:
16371870
15.

The immunogenicity and reactogenicity of the trivalent vaccine, Trimovax, indicated for prevention of measles, mumps, and rubella, in 12-month-old children in Belarus.

Samoilovich EO, Kapustik LA, Feldman EV, Yermolovich MA, Svirchevskaya AJ, Zakharenko DF, Fletcher MA, Titov LP.

Cent Eur J Public Health. 2000 Aug;8(3):160-3.

PMID:
10965439
16.

Effective antibody response in newborn babies living in Maldives to simultaneous vaccination against hepatitis B, poliomyelitis, diphtheria and tetanus.

Da Villa G, Picciotto L, Ribera G, Bencivenga M, Cotugno M, Hartmann P.

Vaccine. 1995 Jun;13(9):795-8.

PMID:
7483799
17.

Evaluation of immunity status to routine vaccination in pediatric liver transplant candidates.

Dehghani SM, Shakiba MA, Ziaeyan M, Imanieh MH, Haghighat M, Sedaghat M, Alborzi A, Malek-Hosseini SA.

Turk J Gastroenterol. 2014 Dec;25 Suppl 1:26-31. doi: 10.5152/tjg.2014.5139.

18.

Need for monitoring vaccinated populations for immunity levels.

Horstmann DM.

Prog Med Virol. 1973;16:215-40. Review. No abstract available.

PMID:
4585486
20.

Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age.

Redd SC, King GE, Heath JL, Forghani B, Bellini WJ, Markowitz LE.

J Infect Dis. 2004 May 1;189 Suppl 1:S116-22.

PMID:
15106100

Supplemental Content

Support Center